Hinova Pharmaceuticals, Inc. Class ASSE: 688302

2025 Semi-annual Report

Aug 14, 2025 · Issued by Hinova Pharmaceuticals, Inc. Class A via Shanghai Stock Exchange

2025 Semi-annual Report

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment